Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes

被引：0
|
作者：
Venexia M. Walker
Marijana Vujkovic
Alice R. Carter
Neil M. Davies
Miriam S. Udler
Michael G. Levin
George Davey Smith
Benjamin F. Voight
Tom R. Gaunt
Scott M. Damrauer
机构：
[1] MRC University of Bristol Integrative Epidemiology Unit,Bristol Medical School: Population Health Sciences
[2] University of Bristol,Department of Surgery
[3] University of Pennsylvania Perelman School of Medicine,Department of Medicine
[4] University of Pennsylvania Perelman School of Medicine,K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU
[5] Norwegian University of Science and Technology,Center for Genomic Medicine
[6] Massachusetts General Hospital,Division of Cardiovascular Medicine
[7] University of Pennsylvania Perelman School of Medicine,Department of Systems Pharmacology and Translational Therapeutics
[8] Corporal Michael Crescenz VA Medical Center,Department of Genetics
[9] University of Pennsylvania Perelman School of Medicine,Institute of Translational Medicine and Therapeutics
[10] University of Pennsylvania Perelman School of Medicine,undefined
[11] University of Pennsylvania Perelman School of Medicine,undefined
来源：
Diabetologia | 2022年 / 65卷
关键词：
Atherosclerotic cardiovascular disease; Coronary artery disease; Direct effect; Genome-wide association study; Indirect effect; Mediation; Mendelian randomisation; Peripheral artery disease; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：790 / 799
页数：9
相关论文
共 50 条
  • [1] Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes
    Walker, Venexia M.
    Vujkovic, Marijana
    Carter, Alice R.
    Davies, Neil M.
    Udler, Miriam S.
    Levin, Michael G.
    Smith, George Davey
    Voight, Benjamin F.
    Gaunt, Tom R.
    Damrauer, Scott M.
    DIABETOLOGIA, 2022, 65 (05) : 790 - 799
  • [2] Lipoprotein(a) in atherosclerotic cardiovascular disease, type 2 diabetes, and liver disease
    Williams, Kathryn L.
    Augustine, Maya
    Sujakhu, Eru
    Magadia, Justine
    Crawford, Lindsay
    Knott, Aimee
    Hamilton, Skyler
    Obiaka, Uzoma
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2025, 76
  • [3] Estimation of atherosclerotic cardiovascular disease risk in type 2 diabetes
    Cai Xiaoling
    Lin Chu
    Ji Linong
    中华医学杂志英文版, 2022, 135 (21)
  • [4] Estimation of atherosclerotic cardiovascular disease risk in type 2 diabetes
    Cai, Xiaoling
    Lin, Chu
    Ji, Linong
    CHINESE MEDICAL JOURNAL, 2022, 135 (21) : 2605 - 2607
  • [5] LIPOPROTEIN(A) AND PREVALENT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN PATIENTS WITH TYPE 2 DIABETES
    Barkas, F.
    Koutsogianni, A.
    Adamidis, P.
    Anastasiou, G.
    Sakkou, S. -F.
    Kyrili, K.
    Liamis, G.
    Liberopoulos, E.
    ATHEROSCLEROSIS, 2022, 355 : E136 - E137
  • [6] Atherosclerotic cardiovascular disease among patients with type 2 diabetes in Basrah
    Mansour, Abbas Ali
    Ajeel, Narjis A. H.
    WORLD JOURNAL OF DIABETES, 2013, 4 (03) : 82 - 87
  • [7] Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease
    Filippatos, Gerasimos
    Anker, Stefan D.
    Pitt, Bertram
    McGuire, Darren K.
    Rossing, Peter
    Ruilope, Luis M.
    Butler, Javed
    Jankowska, Ewa A.
    Michos, Erin D.
    Farmakis, Dimitrios
    Farjat, Alfredo E.
    Kolkhof, Peter
    Scalise, Andrea
    Joseph, Amer
    Bakris, George L.
    Agarwal, Rajiv
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 9 (01) : 85 - 93
  • [8] Severity of hepatic steatosis is associated with atherosclerotic cardiovascular disease and type 2 diabetes mellitus
    Ayonrinde, Oyekoya
    Adams, Leon A.
    Mori, Trevor
    Melton, Phillip
    Olynyk, John
    Zelesco, Marilyn
    Mould, Andrea
    Fiori, James
    Beilin, Lawrence
    Dwivedi, Girish
    Sanfilippo, Frank
    Welman, Christopher
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 130 - 130
  • [9] Optimization of Medication Regimens in Patients with Type 2 Diabetes and Clinical Atherosclerotic Cardiovascular Disease
    Prudencio, Jarred
    Cajudoy, Paige
    Waddell, Donald
    PHARMACY, 2021, 9 (04)
  • [10] Genetic Susceptibility to Type 2 Diabetes, Television Viewing, and Atherosclerotic Cardiovascular Disease Risk
    Wang, Mengyao
    Collings, Paul James
    Day, Felix R.
    Ong, Ken K.
    Brage, Soren
    Sharp, Stephen J.
    Jang, Haeyoon
    Suh, Siyeon
    Luo, Shan
    Yeung, Shiu Lun Au
    Kim, Youngwon
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (06):
12345